Laurel Habel to Phosphodiesterase 5 Inhibitors
This is a "connection" page, showing publications Laurel Habel has written about Phosphodiesterase 5 Inhibitors.
Connection Strength
0.559
-
Use of sildenafil or other phosphodiesterase inhibitors and risk of melanoma. Br J Cancer. 2016 09 27; 115(7):895-900.
Score: 0.559